Alta Biopharma Partners Ii Lp - Net Worth and Insider Trading

Alta Biopharma Partners Ii Lp Net Worth

The estimated net worth of Alta Biopharma Partners Ii Lp is at least $240 Million dollars as of 2024-11-13. Alta Biopharma Partners Ii Lp is the 10% Owner of Corcept Therapeutics Inc and owns about 4,150,655 shares of Corcept Therapeutics Inc (CORT) stock worth over $240 Million. Details can be seen in Alta Biopharma Partners Ii Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alta Biopharma Partners Ii Lp has not made any transactions after 2007-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alta Biopharma Partners Ii Lp

To

Alta Biopharma Partners Ii Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alta Biopharma Partners Ii Lp owns 3 companies in total, including SCYNEXIS Inc (SCYX) , Corcept Therapeutics Inc (CORT) , and Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of Alta Biopharma Partners Ii Lp’s form 4 insider trades.

Insider Ownership Summary of Alta Biopharma Partners Ii Lp

Ticker Comapny Transaction Date Type of Owner
SCYX SCYNEXIS Inc 2014-05-02 10 percent owner
CORT Corcept Therapeutics Inc 2007-08-17 10 percent owner
RIGL Rigel Pharmaceuticals Inc 2004-02-19 10 percent owner

Alta Biopharma Partners Ii Lp Latest Holdings Summary

Alta Biopharma Partners Ii Lp currently owns a total of 1 stock. Alta Biopharma Partners Ii Lp owns 4,150,655 shares of Corcept Therapeutics Inc (CORT) as of August 17, 2007, with a value of $240 Million.

Latest Holdings of Alta Biopharma Partners Ii Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2007-08-17 4,150,655 57.79 239,866,352

Holding Weightings of Alta Biopharma Partners Ii Lp


Alta Biopharma Partners Ii Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Alta Biopharma Partners Ii Lp has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 0 shares on August 17, 2007, which brought Alta Biopharma Partners Ii Lp around $0.

Insider Trading History of Alta Biopharma Partners Ii Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alta Biopharma Partners Ii Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alta Biopharma Partners Ii Lp Ownership Network

Ownership Network List of Alta Biopharma Partners Ii Lp

No Data

Ownership Network Relation of Alta Biopharma Partners Ii Lp

Insider Network Chart

Alta Biopharma Partners Ii Lp Owned Company Details

What does SCYNEXIS Inc do?

Who are the key executives at SCYNEXIS Inc?

Alta Biopharma Partners Ii Lp is the 10 percent owner of SCYNEXIS Inc. Other key executives at SCYNEXIS Inc include Chief Medical Officer Gonzalez David Angulo , Chief Financial Officer Ivor Macleod , and General Counsel Scott Sukenick .

SCYNEXIS Inc (SCYX) Insider Trades Summary

Over the past 18 months, Alta Biopharma Partners Ii Lp made no insider transaction in SCYNEXIS Inc (SCYX). Other recent insider transactions involving SCYNEXIS Inc (SCYX) include a net purchase of 20,000 shares made by Gonzalez David Angulo ,

In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SCYNEXIS Inc Insider Transactions

No Available Data

Alta Biopharma Partners Ii Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Alta Biopharma Partners Ii Lp. You might contact Alta Biopharma Partners Ii Lp via mailing address: One Embarcadero Center, Suite 3700, San Francisco Ca 94111.